We’re proud to showcase the dynamic companies within the Founders at the University of Cambridge START accelerator programmes. Powering growth through science, each founding team is transforming IP-rich, deep tech ideas into companies that address global challenges, from climate change and mental health to treating diseases and improving food security.
Our Investor Day Lookbooks for START 1.0 and START 2.0 provide insights into the innovation and ingenuity these companies have created whilst reaching this new milestone of commercialising their life-long research. Take a look at…
Developing rapid, simple and precise mental health measurement using innovative technologies. Its age-specific platforms enable efficient mental health assessments to identify those in need of support.
Gastrobody Therapeutics is developing ultra-stable antibody mimetics capable of withstanding the harsh acidic and protease-rich conditions of the GI tract.
Using AI to make brain health more intelligent, Prodromic is accelerating the development of new treatments to ensure each person gets the right intervention at the right time.
Sqwish is the smart performance layer sitting between AI apps and model providers — dynamically optimising speed, performance, cost and reliability at scale, so developers get the best results without the overhead.
Trismik is dedicated to revolutionising the field of Large Language Model (LLM) testing, providing an adversarial platform that enhances model accuracy, safety, and alignment with societal values.
A new quantum computing company operating in the semiconductor space, currently in stealth mode.
Aetosense
AetoSense is on a mission to revolutionise control strategies around air quality with innovative ultrafine particle monitoring solutions. Their focus is on the critical impact of airborne particles on health and energy efficiency.
By inhibiting biofilms, BioTryp’s technology has the potential to revolutionise how we treat infection, providing a much-needed alternative to traditional antibiotic treatment.
Using proprietary marine microbes, BravelyCultured is replacing animal, tropical oil, and petroleum-based products, starting with eco-friendly biosurfactants to replace their petroleum-derived counterparts.
Molyon is producing the next-gen energy storage solution: the lithium-sulfur battery. Offering long-life batteries with twice the energy density of current lithium-ion batteries, at a fraction of the price due to more abundant materials.
Nanomation provides computer-vision software to the semiconductor industry, enabling clients to manufacture with advanced nanomaterials that are otherwise not usable within industry settings.
Protonera aims to realise the scalability of a novel plastic upcycling technology to transform waste plastics into green hydrogen and other value-added commodities.
Solving the biggest problem towards net-zero, fixing the UK electricity grid. VOLTQUANT offers the world’s first search engine for grid connections, empowering developers to connect seamlessly using a machine-learning-enabled platform.
William Oak Diagnostics is developing a point-of-care test for micronutrient deficiencies for maternal, infant and child health, bringing a better standard of health around the world.
Xterna’s technology identifies different cell types in the human body through engineered cell-specific binders. These binders could be used for diagnostics or coupled with therapeutics to aid drug delivery to specific cells.
BE THE FIRST TO HEAR ABOUT LATEST NEWS AND EVENTS
By submitting the form below you consent to Founders at the University of Cambridge contacting you by email in relation to news and updates.